WELLBUTRIN - 64455-731-07 - (bupropion hydrochloride)

Alphabetical Index


Drug Information of WELLBUTRIN

Product NDC: 64455-731
Proprietary Name: WELLBUTRIN
Non Proprietary Name: bupropion hydrochloride
Active Ingredient(s): 300    mg/1 & nbsp;   bupropion hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of WELLBUTRIN

Product NDC: 64455-731
Labeler Name: BTA Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021515
Marketing Category: NDA
Start Marketing Date: 20091223

Package Information of WELLBUTRIN

Package NDC: 64455-731-07
Package Description: 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (64455-731-07)

NDC Information of WELLBUTRIN

NDC Code 64455-731-07
Proprietary Name WELLBUTRIN
Package Description 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (64455-731-07)
Product NDC 64455-731
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bupropion hydrochloride
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20091223
Marketing Category Name NDA
Labeler Name BTA Pharmaceuticals
Substance Name BUPROPION HYDROCHLORIDE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]

Complete Information of WELLBUTRIN


General Information